Zealand Pharma A/S (ZLDPF)
43.00
0.00 (0.00%)
USD |
OTCM |
Sep 15, 16:00
Zealand Pharma Price to Book Value : 1.090 for Sept. 15, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 15, 2026 | 1.090 |
| September 14, 2026 | 1.090 |
| September 11, 2026 | 1.176 |
| September 10, 2026 | 1.176 |
| September 09, 2026 | 1.176 |
| September 08, 2026 | 1.176 |
| September 04, 2026 | 1.208 |
| September 03, 2026 | 1.208 |
| September 02, 2026 | 1.199 |
| September 01, 2026 | 1.199 |
| August 31, 2026 | 1.181 |
| August 28, 2026 | 1.250 |
| August 27, 2026 | 1.250 |
| August 26, 2026 | 1.314 |
| August 25, 2026 | 1.314 |
| August 24, 2026 | 1.223 |
| August 21, 2026 | 1.281 |
| August 20, 2026 | 1.268 |
| August 19, 2026 | 1.268 |
| August 18, 2026 | 1.244 |
| August 17, 2026 | 1.244 |
| August 14, 2026 | 1.336 |
| August 13, 2026 | 1.336 |
| August 12, 2026 | 1.314 |
| August 11, 2026 | 1.314 |
| Date | Value |
|---|---|
| August 10, 2026 | 1.281 |
| August 07, 2026 | 1.281 |
| August 06, 2026 | 1.204 |
| August 05, 2026 | 1.204 |
| August 04, 2026 | 1.204 |
| August 03, 2026 | 1.204 |
| July 31, 2026 | 1.180 |
| July 30, 2026 | 1.180 |
| July 29, 2026 | 1.180 |
| July 28, 2026 | 1.180 |
| July 27, 2026 | 1.142 |
| July 24, 2026 | 1.142 |
| July 23, 2026 | 1.142 |
| July 22, 2026 | 1.131 |
| July 21, 2026 | 1.154 |
| July 20, 2026 | 1.154 |
| July 17, 2026 | 1.128 |
| July 16, 2026 | 1.138 |
| July 15, 2026 | 1.138 |
| July 14, 2026 | 1.138 |
| July 13, 2026 | 1.138 |
| July 10, 2026 | 1.138 |
| July 09, 2026 | 1.138 |
| July 08, 2026 | 1.148 |
| July 07, 2026 | 1.148 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Genmab A/S | 3.423 |
| Ascendis Pharma A/S | 9.588 |
| Bavarian Nordic A/S | 1.177 |
| Evaxion AS | 2.660 |
| ACADIA Pharmaceuticals, Inc. | 3.525 |
Price to Book Value Related Metrics
| PE Ratio | 7.168 |
| PS Ratio | 4.20 |
| Price | 43.00 |
| Earnings Yield | 13.95% |
| Market Cap | 3.002B |
| Operating PE Ratio | 8.333 |
| Normalized PE Ratio | 7.111 |